18046082|t|Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.
18046082|a|BACKGROUND/AIMS: Lipoprotein glomerulopathy (LPG) is a rare disease characterized by thrombus-like substances in markedly dilated glomerular capillaries and elevated plasma levels of apolipoprotein E (apoE). Previous studies have shown that genetic disorders of apoE may contribute to the pathogenesis of LPG, but LPG may not be caused by apoE gene mutations in Chinese patients. This study investigated the association of a new variant of apoE with LPG in a Chinese family. METHODS: The apoE gene in a family with 4 LPG patients was sequenced. The polymerase chain reaction product of coding region of apoE exon 4 was cloned into pMD 18-T vector and then sequenced. RESULTS: A novel point mutation in exon 4 of the apoE gene was identified in all 4 LPG patients and 1 asymptomatic family member. Sequence analysis confirmed a nucleotide G to C point mutation in exon 4 (base 308) of the apoE gene in all patients and the asymptomatic family member. This missense mutation denotes amino acid substitution of the proline residue for arginine residue at position 150 of apoE. Those patients were all heterozygotes with apoE Guangzhou. One of 2 grandsons was a heterozygous carrier of apoE Guangzhou, although he did not have proteinuria. CONCLUSION: The results of this study suggest that apoE (arginine 150 proline) is a novel apoE variant that etiologically related to LPG. This variant (apoE Guangzhou) may cause a marked molecular conformational change of the apoE and thus impair its binding ability to lipids.
18046082	18	34	apolipoprotein E	GeneOrGeneProduct	348
18046082	46	66	arginine 150 proline	SequenceVariant	p|SUB|R|150|P
18046082	99	125	lipoprotein glomerulopathy	DiseaseOrPhenotypicFeature	C567089
18046082	144	170	Lipoprotein glomerulopathy	DiseaseOrPhenotypicFeature	C567089
18046082	172	175	LPG	DiseaseOrPhenotypicFeature	C567089
18046082	212	220	thrombus	DiseaseOrPhenotypicFeature	D013927
18046082	249	279	dilated glomerular capillaries	DiseaseOrPhenotypicFeature	D007674
18046082	310	326	apolipoprotein E	GeneOrGeneProduct	348
18046082	328	332	apoE	GeneOrGeneProduct	348
18046082	389	393	apoE	GeneOrGeneProduct	348
18046082	432	435	LPG	DiseaseOrPhenotypicFeature	C567089
18046082	441	444	LPG	DiseaseOrPhenotypicFeature	C567089
18046082	466	470	apoE	GeneOrGeneProduct	348
18046082	497	505	patients	OrganismTaxon	9606
18046082	567	571	apoE	GeneOrGeneProduct	348
18046082	577	580	LPG	DiseaseOrPhenotypicFeature	C567089
18046082	615	619	apoE	GeneOrGeneProduct	348
18046082	644	647	LPG	DiseaseOrPhenotypicFeature	C567089
18046082	648	656	patients	OrganismTaxon	9606
18046082	730	734	apoE	GeneOrGeneProduct	348
18046082	843	847	apoE	GeneOrGeneProduct	348
18046082	877	880	LPG	DiseaseOrPhenotypicFeature	C567089
18046082	881	889	patients	OrganismTaxon	9606
18046082	965	1007	G to C point mutation in exon 4 (base 308)	SequenceVariant	c|SUB|G|308|C
18046082	1015	1019	apoE	GeneOrGeneProduct	348
18046082	1032	1040	patients	OrganismTaxon	9606
18046082	1139	1191	proline residue for arginine residue at position 150	SequenceVariant	p|SUB|R|150|P
18046082	1195	1199	apoE	GeneOrGeneProduct	348
18046082	1207	1215	patients	OrganismTaxon	9606
18046082	1244	1248	apoE	GeneOrGeneProduct	348
18046082	1309	1313	apoE	GeneOrGeneProduct	348
18046082	1350	1361	proteinuria	DiseaseOrPhenotypicFeature	D011507
18046082	1414	1418	apoE	GeneOrGeneProduct	348
18046082	1420	1440	arginine 150 proline	SequenceVariant	p|SUB|R|150|P
18046082	1453	1457	apoE	GeneOrGeneProduct	348
18046082	1496	1499	LPG	DiseaseOrPhenotypicFeature	C567089
18046082	1515	1519	apoE	GeneOrGeneProduct	348
18046082	1589	1593	apoE	GeneOrGeneProduct	348
18046082	1633	1639	lipids	ChemicalEntity	D008055
18046082	Association	c|SUB|G|308|C	D008055	Novel
18046082	Bind	348	D008055	No
18046082	Association	348	C567089	No
18046082	Association	p|SUB|R|150|P	D008055	Novel
18046082	Association	p|SUB|R|150|P	C567089	Novel